How long can Lurbinectedin be used?

LurbinectedinThe duration of use typically varies based on the patient's specific condition, cancer type, treatment regimen, and efficacy. The duration of treatment is usually determined by the physician based on the patient's clinical condition and response to treatment. Here are some factors that may affect how long Rubicatin should be used:

1.Cancer type and stage: The type and stage of cancer will affect the duration of treatment. Some cancers may require longer treatment, while others may only require short-term treatment.

2.Treatment goals: The goals of treatment are also an important factor. In some cases, the goals of treatment may be to relieve symptoms and control the disease, while in other cases, it may be to attempt to achieve partial or complete remission.

3.Effectiveness: Patient outcome is a key consideration. If a patient responds well to treatment with rubicatin and the cancer is under control, treatment may last longer. But if the response is poor or the cancer is progressing rapidly, other treatment options may need to be considered.

4.Side effects and tolerance: Rubicatin may be associated with a range of side effects, and patient tolerance and management of side effects will also affect the duration of treatment. If side effects are too severe or uncontrollable, your doctor may need to adjust your treatment plan or discontinue treatment.

Rubicardin has not yet been launched in China, so it is not included in medical insurance. Patients cannot purchase it domestically and need to purchase Rubicatin through overseas channels. There is only the original drug Rubicatin in foreign countries, and the price is relatively expensive. In comparison, the original drug in Singapore is slightly cheaper, priced at more than 30,000, and there are other American versions of the original drug, priced at more than 90,000.